Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On a possible buyout. Yep, this screw job by the fda could be part of something
to corner ATNM management into doing something they weren't prepared to do.
The other question I hadn't really spent much time on yet is, just how good is their
WAR programs? How good/effective is the technology.
.
With the recent price drop the majority shareholders in ATNM may be softened up enough to accept a much lower buyout price for the company but the question is will Seth be willing to sell. If he does it will be before Thanksgiving of this year imo.
Worst part is, their development appears to actually HELP people
So why in the hell would the fda say, redo the trial vs
do a PH 4 follow up trial following approval.
Unfricking real..
Yeah, I sold out some years ago as well, held off taking a new position until recently.
Got a 1000 shares at $7.55, have $900 in profits off the covered calls. So going to keep doing that
while this gets figured out. Only concern is whats going to happen to the value of the calls as this
quiets down.. Might be tough to get a lot for them.
Yep, have seen enough out of the fda to again, realize its integrity has been compromised.. And that
IS NOT a good thing..
But sadly, its just a reflection of the overall breakdown in morals, ethics, integrity, honesty in this world now.
Replaced by the desire for GREED and POWER no matter what gets sacrificed to get it.
Thank you for your reply which confirms my feelings regarding FDA’s lack of integrity surrounding the approval process. I’m happy that I sold about half of my position a couple of years ago (at around 12). I guess we wait for an unsatisfying buyout?
Yep, thats my understanding as well. They concurred in the trial, which means they
had agreed on the 'acceptance' criteria.
But at least this explains WHY its taken them so long to announce filing for approval.
And been a long time observer/concluder that the FDA doesn't have the publics best
interest as their primary goal. Figured it out some years ago that big pharma runs the
fda, guides its 'decisions'.
Even to the point where I have suspected that new ideas trying that are 'targets' by
a big pharma who would like to own the idea, may find it harder to get to their end point.
To the point they become illiquid and forced to 'negotiate' just so that the developers can
get something for their efforts.
Or even worse, in this case, since this does appear to HELP people going thru treatment,
that despite this conclusion, the fda doesn't give a damn that it does. And once again, instead
of saying, we will approve but you have to do a PH 4 followup to conclude just how well it works.
We are going to flat out DENY the ones that could benefit from this from using it to help extend/save
their lives. Nope, we are going to endanger lives instead by DENYING them a potential treatment
that has shown it can help them. That to me is the really sick part of this mess.
Yep, sure appears to be a royal screw job. Not just for ATNM, but really for those that it could HELP.
I believe it was Astra Zenica buying Force Pharmaceuticals?
Actinium Provides Regulatory Update on Planned BLA Filing and Future Plans for Iomab-B in the U.S.
Can they get approval outside the US?
Perhaps a new partner is on the bid…?
With deep pockets…
Did the drug makers pressure fda to force this?
Did some company like ABBV or ABT or GSK buy that other Actinium using company?
There are other companies that use the radio therapeutic actinium investigationally. FDA has approved its use in clinical trials to treat prostate, breast and other solid tissue cancers, but, I couldn’t find any information on any company that holds marketing approval.
Didn’t FDA just approve another company’s drug that also contained actinium?
I think they are mostly big pharma- centered. The deck is truly stacked against the smaller players. It’s a shame because most of the true innovation comes from the small guys!
FDA is a criminal agency. How could exert a pressure on patients not to cross over when it comes to life and death. FDA needs to use ECA and other documented data to compare and evaluate the results.
The message from the company is that they have to run a whole new trial (apparently without a cross over option)
Now what kind of test they want to run? Is it full trial size or what?
Wow. The FDA really screwed us on this one. One must question if the FDA really has the public’s interest in mind when making these decisions. If I’m understanding it correctly, FDA approved the SIERRA study, even went so far as to say that it would be enough to garner approval, then decided that it wasn’t enough to file a BLA?
fda just screwed ATNM over by telling them the trials acceptance criteria (which the FDA 'accepted' when the trial was
put together) needs to be changed.
https://ir.actiniumpharma.com/press-releases/detail/486
Would like to see them get their NDA submitted already.
Be nice to see them advancing their first product to market to start generating
some revenues.
For everything else they are 'spending' cash on is years from generating revenue unless
its good enough for them to be bought out or gain a partnership.
Today’s news was interesting in that atnm Will start on path developing new method to treat sickle cell cases. This will have the attention of.Vertex as an alternative to chemo. VRTX is working with CRSP on their first approved treatment using CRSPR TECHNOLOGY for sickle disease . It would be quite nice for.ATNM to rub shoulders withVRTX and CRSP as they have very deep pockets! Might pull in those calls LOL
LOL...
Nope, been a while since I was serious about holding shares for the NDA submission.
But noticed the calls have some 'value' to them, and also that accumulation occurred in
APRIL, MAY and its happening again now. (have a sentiment indicator I monitor on the
charting software I use)..
Should actually send a message to their IR and ask them to update folks on their
NDA submission status. Like what in the heck is taking so long (smile)
Not much posting here, so you are the one buying all the shares to take it to $10?
Thank you
No really it is moving up nicely
Started my accumulation of shares this morn.
But also selling covered calls on the shares while I wait.
Got shares at $7.55 and sold the Sept $10 Strike price for .55 cents/..
good way to get some gains, hopefully hold onto the shares in the process.
Good luck.
The time to be in is right before close on Friday. News could be over the weekend and Monday morning nice gap and run.
ATNM with BLA news, should realistically hit 30 dollars minimum in multiple days.
Way too much manipulation on level 2, been watching the trades for the past 2 weeks, that is why I got in yesterday.
Who knows BLA is suppose to be this month, not holding my breath though. Either this month or sometime in after July 4th. What I am seeing is people getting in for news everyday and when news doesn't come they sell the next day.
I don't own any at the moment. Been a while actually since I have held any position for that matter
That said, with the announcement of the filing of the NDA anticipated sometime between the end of
June and December??
Been thinking of 'playing' the announcement. But at the moment, ATNM is in a confirmed
downtrend. So going to be patient to see what this gets down to first..
Do like the Nov %5s for $3.20/ 2x as many vs the shares and only a $ in 'premium'.
But again, see how low this goes first..
Good luck
Bought 90 calls all the way out to November in the money, also bought 1500 shares at the end of day.
popping on the news of a PH 1 trial.. so they buying to take what
the news 'gives' this morn or are they buying to hold the shares for
the next 2 - 2+ years till the PH 2 is over and reads out
Just read their MAY 2024 presentation and see they are now
targeting the 2nd HALF of 2024 for an NDA on IO-B.. taking a
long time to get this NDA submitted, and then take on another 9
months for a decision. Mercy...
IE, don't expect the share price to do much until they announce the NDA submission now,
and then it will be up to the PH 2s on the ARC developments to give us insights into what its
potential really is..
Good luck
Maybe soon. ATNM trading at $8.40 this morning, pre-market opening, +7.42%.
Good luck. Something’s gotta give soon! I’d love to see that 25 dollar mark before the end of the year.
Back in with the first buy in a long time... Still have a target price of $25.. Ticked that CRMD has taken so long to get going cause it made me miss one heck of a buying opp on ATNM sub $5...
Now to start selling covered calls and see if I can keep the shares..
Good luck..
The troll idiot rides again making up lies when his ass gets burned.
LMAO, what a piece of work.
LOL!! Is this your "timing" post?? Yes, you only made it 8 years ago....great timing....of course the stock was around $62 then
Monroe1
Re: None
Tuesday, September 27, 2016 10:17:02 AM
Post#
1092
of 2790
So what is the ETA for lomab coming out of phase3 and approval?
Mid 2017 or earlier perhaps??
Suppose that PT is raised in light of AZN buying Fusion at ~ 100% premium today? Much needed Actinium involved there also
Maxim Group Maintains Buy on Actinium
Pharma, Raises Price Target to $30
3/19/2024 12:59pm
12:59 PM EDT, March 19, 2024 (Benzinga Newswire)
Maxim Group analyst Jason McCarthy maintains
Actinium Pharma (AMEX:ATNM) with a Buy and raises the price target from $20 to $30.
Write to Benzinga at editorial@benzinga.com
I continue to believe that potential suitors are waiting for ATNM to, at the very least, submit their application to the FDA. Possibly the company even had some offers but would be in a better position to negotiate after approval?
Watching Actinium Pharmaceuticals; HC
Wainwright: First Take Says 'Appetite Remains High For Radiopharmaceuticals;
We See Actinium As Ripe For Takeout And Believes It Is Receiving M&A Interest'
3/19/2024 11:24am
HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target
3/19/2024 11:19am
11:19 AM EDT, March 19, 2024 (Benzinga Newswire)
HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.
Write to Benzinga at editorial@benzinga.com
Good news but we can sure use that FDA submission.
Actinium Pharmaceuticals Disclosed The Launch Of Strategic Initiative Focused On The Manufacture Of The Highly Sought After Medical Isotope Actinium-225 (Ac-225)
3/14/2024 6:11am
Yes, but I also think many thought that the company was setting up for a pr letting us know they finally applied for FDA approval. I still think they will- but probably later this year.
Perhaps it is the result of a delayed market reaction to the ATNM PR dated 2/28/2024.
There were a couple of articles/abstracts that were recently published that were positive for one of the companies products ( I believe it was Iomab?). I think the presumption was that the company was soon going to submit for FDA approval for that product. No word as of yet to that end.
Anyone know why we have moved from $4 to the high of $8.78?
I should have bought more at $4 but I don’t think we are going to see that again.
How to calculate the value of drugs and biotech companies
https://www.baybridgebio.com/drug_valuation.html
Followers
|
161
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2827
|
Created
|
04/17/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |